The progressive shortening of telomeres at each cell division is a key mech
anism in controlling cell proliferative capacity, The activation of telomer
ase, a reverse transcriptase that extends telomere length, potentially lead
s to unlimited cell proliferation, and is believed to play a critical role
in the neoplastic process. High levels of telomerase activity have been dem
onstrated in almost all solid tumours, however. little data is available co
ncerning its expression in chronic B-cell neoplasms. By using a quantitativ
e polymerase chain reaction-based method we quantified telomerase activity
in normal B lymphocytes, and in various B-cell malignancies, including chro
nic lymphocytic Leukaemia (CUI, mantle cell lymphoma (MCL) and hairy cell l
eukaemia (HCL). Compared to normal B cells, which expressed very low levels
of telomerase activity malignant cells from most of the patients showed a
significant increase in telomerase activity, with highest values observed i
n HCL samples. Moreover, among the CLL and HCL cases, significantly higher
levels of telomerase activity were found in patients with progressive disea
se at 1 year follow-up versus patients with stable disease, These data sugg
est that telomerase activity might correlate with disease progression.